Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02232009 · ClinicalTrials.gov registry record · NA
Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit
A NA study, sponsored by GE Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02232009: Clinical Trial NA study, sponsored by GE Healthcare.
NCT02232009 is a NA study that was terminated before completion, run by GE Healthcare. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02232009, a NA study, was terminated before completion, sponsored by GE Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth - 1 month) and infants (less than 1 month to two years), such as clinical neonatal intensive care units (NICUs) and other infant and neonatal care departments.
Primary Outcome
Safety will be assessed based on the number of Adverse Events.
Interventions
- DEVICE 3.0 T Neonatal MRI Scanner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05-07 |
| Est. Completion | 2016-11-30 |
| Phase | NA |
Why NCT02232009 stopped before completion
NCT02232009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which 3.0 T Neonatal MRI Scanner is the first listed.
NCT02232009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02232009 about?
NCT02232009 is a clinical study titled "Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit". This study investigates a novel magnetic resonance imaging (MRI) system designed by GEHC for imaging viable neonate and infant populations. This MR system has a smaller size and design features that may make it more feasible to locate the system in close proximity to care areas for neonates (birth -...
What is the current status of trial NCT02232009?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2015-05-07. Estimated completion is 2016-11-30.
What interventions are being tested in trial NCT02232009?
The interventions under investigation include: 3.0 T Neonatal MRI Scanner (DEVICE).
Who is sponsoring clinical trial NCT02232009?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02232009's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI